Industry News
How Lymphoma Evolves - A Study Of Two Sisters
Dec 13, 2011
A 41-year-old woman with chronic-phase chronic myeloid leukemia received a bone marrow transplant and subsequent leukocyte infusion from her sister to control her leukemia, however seven years on, both sisters developed follicular lymphoma... Read More
How Do BRCA1 Mutations Harm Breast Cells? Researchers Demonstrate
Dec 13, 2011
Researchers at the Johns Hopkins Kimmel Cancer Center have demonstrated during their work with breast cells that breast cells become vulnerable to cancer if a single copy of the breast cancer gene BRCA1 is inactivated. It causes genetic instability in the cells through reducing their ability to repair DNA damage... Read More
Cancer Vaccine Significantly Reduces Tumor Size
Dec 13, 2011
An experimental cancer vaccine has been found to reduce tumor size by an average of 80%, researchers from the Mayo Clinic and the University of Georgia reported in Proceedings of the National Academy of Sciences... Read More
Immune Response To Multiple Myeloma Stimulated By Peptide 'Cocktail'
Dec 13, 2011
Scientists at Dana-Farber Cancer Institute have created a "cocktail" of immune-stimulating peptides they believe could provoke the body's defenses to attack multiple myeloma in its early "smoldering" phase and slow or prevent the blood cancer... Read More
A Two-Faced Leukemia?
Dec 13, 2011
One kind of leukemia sometimes masquerades as another, according to a study published online this week in the Journal of Experimental Medicine*. Leukemia results when normal immune cells accumulate mutations that drive uncontrolled growth. T cell acute lymphoblastic leukemia (T-ALL) derives from immature T cells, whereas acute myeloid leukemia (AML) comes from myeloid cells... Read More
Understanding How Brain Tumors Invade
Dec 13, 2011
Scientists have pinpointed a protein that allows brain tumors to invade healthy brain tissue, according to work published this week in the Journal of Experimental Medicine*. 40% of a common but deadly type of brain tumor - called glioblastoma multiforme (GBM) - have mutations in a gene that encodes a protein called epidermal growth factor receptor (EGFR)... Read More
In Pre-Leukemic Cells, 'PARP' Drug Sabotages DNA Repair
Dec 13, 2011
Looking for ways to halt the uncontrolled growth of cancer cells, scientists at Johns Hopkins have found that a new class of drugs, called PARP inhibitors, may block the ability of pre-leukemic cells to repair broken bits of their own DNA, causing these cells to self-destruct... Read More
Vaccine Developed That Attacks Breast Cancer In Mice; Implications For Ovarian, Colorectal And Pancreatic Cancers
Dec 13, 2011
Researchers from the University of Georgia and the Mayo Clinic in Arizona have developed a vaccine that dramatically reduces tumors in a mouse model that mimics 90 percent of human breast and pancreatic cancer cases - including those that are resistant to common treatments... Read More
Cognitive Problems Still Evident Several Years After Breast Cancer Treatment
Dec 13, 2011
A new analysis has found that breast cancer survivors may experience problems with certain mental abilities several years after treatment, regardless of whether they were treated with chemotherapy plus radiation or radiation only... Read More
Outpatients Experience The Most Cancer-Related Blood Clots
Dec 13, 2011
In a study of nearly 18,000 cancer patients, University of Rochester Medical Center researchers found that when blood clots develop - a well-known and serious complication of cancer treatment - 78 percent of the time they occur when a person is out of the hospital, at home or elsewhere, while on chemotherapy... Read More
Previous Page Next Page